# Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis

> **NCT07728201** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University** · enrollment: 30 (estimated)

## Conditions studied

- Langerhans Cell Histiocytosis

## Interventions

- **DRUG:** Luvometinib
- **DRUG:** Luvometinib, Cytarabine.

## Key facts

- **NCT ID:** NCT07728201
- **Lead sponsor:** Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2028-07-31
- **Final completion:** 2030-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728201, "Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*